Yiling Pharmaceutical Ltd

Shijiazhuang, ChinaFEI 3011640199

Yiling Pharmaceutical Ltd is a drug establishment in Shijiazhuang, China, registered with the US FDA under FEI 3011640199. Its registered operations are: Drug manufacture. 3 EU/UK GMP certificates are matched to this site, 2 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Drug manufacture

GMP documents matched to this site (3)

DocumentAuthorityInspectionSource
UK GMP 46327 Insp GMP 46327/14556948-0005[H]
GMP certificate
MHRA13 Jul 2026
within 3-year review window
MHRA-GMDP
UK GMP 46327 Insp GMP 46327/14556948-0004[H]
GMP certificate
MHRA13 Jul 2026
within 3-year review window
MHRA-GMDP
UK GMP 46327 Insp GMP 46327/14556948-0002[H]
GMP certificate
MHRA24 Aug 2017
outside 3-year review window
MHRA-GMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.